White Papers
-
Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology
4/11/2025
Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.
-
Reimagining Medical Monitoring In Clinical Research
4/11/2025
Clinical trials are undergoing a transformative shift driven by evolving regulations, advanced technologies, and decentralized methodologies.
-
The Transformation Of Regulatory Processes Through AI, ML, NLP, And RPAs
4/7/2025
Explore the rapidly evolving landscape of regulatory processes as they undergo a profound digital transformation, highlighting how emerging technologies are reshaping traditional regulatory frameworks.
-
Key AI Trial Insights From Regulators And Consultants
4/4/2025
AI’s transformative impact promises more efficient, cost-effective, and successful clinical trials across the pharmaceutical landscape.
-
A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity
3/28/2025
The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.
-
Remote Patient Monitoring Using Mobile Health Technology
3/28/2025
This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment.
-
2025 Trends In Patient Recruitment: From Disruption To Precision
3/27/2025
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
Innovative FSP Solutions For Biopharma Growth And Transition
3/24/2025
To optimize clinical development, the pharmaceutical industry is increasingly adopting innovative outsourcing strategies with CROs.
-
Harnessing RWE For Effective External Control Arms In Clinical Trials
3/24/2025
Real-world evidence (RWE) is transforming clinical trials by enabling the use of external control arms (ECAs), which serve as an alternative to traditional randomized control groups.
-
Safeguarding Personal Data: Protecting PII
3/17/2025
Learn about a secure, patient-centric platform that enables individuals to participate in clinical trials and registries while maintaining lifelong access to their data.